Funded Tech Companies

Amber Therapeutics

Amber Therapeutics is a life sciences company, based in London. Venture capital investment was provided by Intuitive Venture Partners, Oxford Science Enterprises and New Enterprise Associates.

Company Overview

Contact Information

Company Background Information

Overview

Amber Therapeutics was founded in 2021 by Aidan Crawley, Tim Denison, Stefan De Wachter and Charles Knowles with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. We have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Amber UI is the company's first therapy, aiming to restore normal physiological function in women suffering with mixed urinary incontinence.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/10/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Aidan Crawley

        

Chief Marketing Officer

Charles Knowles

        

Chief Scientific Officer

Stefan De Wachter

        

VP - Engineering

Tim Denison

        

VP - Operations

Tomás Furey

        

VP - Regulatory Affairs

Iain Anthony

        

Company Investors

• Intuitive Venture Partners
• Oxford Science Enterprises
• New Enterprise Associates (Tiffany Le)
• 8VC
• F-Prime Capital
• Lightstone Ventures

Browse more funded tech companies:

Amber Technologies | Ambercycle

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary